PSYCHIATRY, INCLUDING PSYCHEDELIC, CLINICAL TRIALS SITE OPENS IN PRIMARY CARE SETTING Novel therapies drive demand for new Paratus Clinical site
With
Megan Morrison,
Chief Executive Officer, Paratus Clinical
Professor Paul Fitzgerald,
Principal Investigator, Paratus Clinical &
Head of School of Medicine and Psychology, Australian National University
Bernadette Fitzgibbon
Director of Psychiatry Research, Paratus Clinical &
Associate Professor, Australian National University
AUSTRALIAN HEALTH JOURNAL SEGMENT
Filmed in Melbourne | August 2025
Over the past decade, Paratus has been involved in over 200 clinical trials across 4 clinical site locations. Now a fifth site, the newly opened Melbourne site will cater to both primary care and psychiatry, specifically designed for psychedelic studies.
The new Melbourne site will be a focused on primary care studies specifically expanding access to psychiatric research, a growing area of unmet need. Australian Health Journal met with 3 recent hires brought in to support clinical trials across the organisation and in psychiatry in Melbourne.
– Megan Morrison, the recently appointed CEO of Paratus Clinical has 24 years of clinical research experience, industry knowledge and leadership, having worked across sponsor, CRO, and now site-side roles.
– Professor Paul Fitzgerald, the Director of the Australian National University School of Medicine and Psychology, provides senior academic leadership at Paratus Clinical as the Principal Investigator. Professor Fitzgerald is a renowned psychiatrist and researcher with over 25 years of experience leading clinical trials focused on psychiatric disorders. His pioneering work includes the development and evaluation of innovative treatments such as neurostimulation therapies (like transcranial magnetic stimulation) and novel pharmacological approaches. He plays a central role in trials in pharmacological-assisted psychotherapy and psychedelic compounds.
With extensive experience in conducting clinical research in psychiatry, Fitzgerald mentors the trial staff and ensures the integrity of the research protocols.
– Bernadette Fitzgibbon, the Director of Psychiatry Research at Paratus Clinical and Associate Professor at the Australian National University, has two decades experience in clinical research. She previously served as Deputy Director of the Monarch Research Institute and is affiliated with both Monash University and the Australian National University, contributing to national research efforts across psychiatry and psychology. She will collaborate closely with Professor Fitzgerald in running clinical trials in Melbourne.
Talking to Australian Health Journal, both Fitzgerald and Fitzgibbon highlight the growing need for innovative treatments in mental health, one which Paratus aims to address through a focused approach to psychiatric research.
Source: Adapted from transcript and Paratus Clinical news posts
You Might also like
-
Patient-paramedic trust can help free up emergency departments
Dr. Robbie King is a Senior Advanced Care Paramedic with the Queensland Ambulance Service and a community paramedic. He is also a lecturer at the Australian Catholic University in Brisbane. After studying paramedicine and working as a student paramedic since 2009, he recognised that most patients attended by ambulance services did not require emergency interventions.
-
Investments to address health inequities in Prostate Cancer Care
Income, education, geographical location, and discrimination based on ethnicity, race, gender and sexual orientation, are only a fraction of factors that can negatively affect a person’s quality of cancer care. This is defined as the “equity gap” and it’s costing people their lives.
Timed to coincide with World Cancer Day 4th February 2025, Movember announced prostate cancer investment of $5.5 million. Eighteen grants (16 proposals and 2 community development grants) are slated to directly tackle inequities in prostate cancer care. The funding will be over three years with the grants spread across five countries – six in Canada, five in the United Kingdom, three in Australia, three in the United States and one in Ireland – each having a specific focus population and care area.
-
Enriching experiences in nursing mentorship
Mentoring in nursing is crucial for the development of nurses and the advancement of the nursing profession. It provides a supportive environment for personal and professional growth, knowledge transfer, and leadership development.
Australian Health Journal met with two nurses both working in Queensland, one the mentor, the other, the mentee. Both get to appreciate the experiences mentorship gives them.